CloudCath, Remote Monitoring Platform for Catheter-Based Treatments
CloudCath’s first served population is End Stage Renal Disease (ESRD) patients that are on Peritoneal Dialysis (PD)


CloudCath, Remote Monitoring Platform for Catheter-Based Treatments
CloudCath’s first served population is End Stage Renal Disease (ESRD) patients that are on Peritoneal Dialysis (PD)
GOALS
Life-Saving Dialysis Rapidly
Moving
To The Home

Setup in Seconds
Setting up the CloudCath Device on a nightly basis is a simple, single step process adding only seconds to the cycler setup process.

Real-Time Results
The CloudCath Device and Patient Management System software tool enables dialysis providers to monitor their patients’ state and progression in real-time.

Fewer Hospitalizations
CloudCath’s monitoring tool enables dialysis providers to intervene much earlier in order to prevent complication escalation.

Preserving Home Modalities
Real-Time remote monitoring of patient metrics enables providers to preserve home treatment modalities for longer, which benefits patients and providers.

Software
Convey Drainage Data Over Time
CloudCath identified a subset of patients that rely on catheter-based treatments in outpatient and acute care settings, in which patients must continuously drain fluid from their body as a core part of a life-sustaining treatment. This fluid is currently discarded. However, CloudCath measures this fluid, which is rich with vital patient data, in order to provide accurate, continuous, and real-time mapping of how complications manifest in our bodies to healthcare providers.
Hardware
IoT Sensing Hardware
User-centric design is core to what we do. The CloudCath Device only takes an additional few seconds to integrate into patients’ clinical flow on a nightly basis. CloudCath does not rely on pairing with Bluetooth or WiFi (by utilizing a built-in LTE module) and the provider portal is passively monitoring while patients are in a healthy state, which minimizes compliance fatigue and information overload for providers.
